Last update 23 Jan 2025

CD70-positive Female Genital Neoplasms

Basic Info

Synonyms-
Introduction-

Related

1
Drugs associated with CD70-positive Female Genital Neoplasms
CD70 CAR-T cells(Chongqing Precision Biotech)
Target
CD70
Mechanism
CD70 modulators [+2]
Active Org.
Chongqing Precision Biotechnology Co., Ltd.Chongqing Precision Biotechnology Co., Ltd.
Originator Org.
Chongqing Precision Biotechnology Co., Ltd.Chongqing Precision Biotechnology Co., Ltd.
Active Indication
CD70-positive Female Genital Neoplasms [+5]
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with CD70-positive Female Genital Neoplasms
NCT06215950
/ RecruitingPhase 1
A Phase I Clinical Study to Assess the Safety and Efficacy of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Gynecologic Cancer
100 Clinical Results associated with CD70-positive Female Genital Neoplasms
Login to view more data
100 Translational Medicine associated with CD70-positive Female Genital Neoplasms
Login to view more data
0 Patents (Medical) associated with CD70-positive Female Genital Neoplasms
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free